Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2

Huo J., Le Bas A., Ruza RR., Duyvesteyn HME., Mikolajek H., Malinauskas T., Tan TK., Rijal P., Dumoux M., Ward PN., Ren J., Zhou D., Harrison PJ., Weckener M., Clare DK., Vogirala VK., Radecke J., Moynié L., Zhao Y., Gilbert-Jaramillo J., Knight ML., Tree JA., Buttigieg KR., Coombes N., Elmore MJ., Carroll MW., Carrique L., Shah PNM., James W., Townsend AR., Stuart DI., Owens RJ., Naismith JH.

DOI

10.1038/s41594-020-0469-6

Type

Journal article

Journal

Nature Structural & Molecular Biology

Publisher

Springer Science and Business Media LLC

Publication Date

09/2020

Volume

27

Pages

846 - 854

Permalink Original publication